Maguate, Gresna .
HRN: 26-05-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/26/2024
11/02/2024
IV
500mg
OD
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes